In this episode of Lung Cancer Considered, host Dr. Stephen Liu moderates a Virtual Tumor Board case exploring the state-of-the-art treatment for extensive stage small cell lung cancer (SCLC) with Dr. Raffaele Califano and Dr. Jessica Menis. There have been several updates to the SCLC paradigm building on first line chemotherapy with immunotherapy including maintenance lurbinectedin and second line tarlatamab. Drs. Califano and Menis review the data and how they approach treatment decisions today.
Podcast Guests: